Passage Bio Inc (PASG)

NASDAQ
2.13
+0.07(+3.40%)
After Hours
2.08
-0.05(-2.35%)
- Real-time Data
  • Volume:
    180,575
  • Day's Range:
    1.99 - 2.14
  • 52 wk Range:
    1.57 - 12.25

PASG Overview

Prev. Close
2.06
Day's Range
1.99-2.14
Revenue
-
Open
2.05
52 wk Range
1.57-12.25
EPS
-3.33
Volume
180,575
Market Cap
116.01M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
445,605
P/E Ratio
-0.60
Beta
1.05
1-Year Change
-80%
Shares Outstanding
54,463,235
Next Earnings Date
Nov 15, 2022
What is your sentiment on Passage Bio?
or
Market is currently closed. Voting is open during market hours.

Passage Bio Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Passage Bio Inc Company Profile

Passage Bio Inc Company Profile

Employees
133

Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 capsid to deliver to the brain a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD-GRN; and PBKR03, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company also develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and PBCM06 for the treatment of Charcot-Marie-Tooth Type 2A. Passage Bio, Inc. has a strategic research collaboration with the Trustees of the University of Pennsylvania’s Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyStrong BuySellSell
Technical IndicatorsStrong BuyStrong BuyBuyBuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Sell
  • So hello
    0